Current Status of 68Ga-Pentixafor in Solid Tumours
Sign Up to like & getrecommendations! Published in 2022 at "Diagnostics"
DOI: 10.3390/diagnostics12092135
Abstract: Chemokine receptor CXCR4 is overexpressed in neoplasms and its expression is related to tumour invasion, metastasis and aggressiveness. 68Ga-Pentixafor is used to non-invasively image the expression of CXCR4 in tumours and has been widely used… read more here.
Keywords: solid tumours; 68ga pentixafor; pentixafor solid; targeting cxcr4 ... See more keywords